Τόμος 20 (2006) – Τεύχος 2 – Άρθρο 44 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 25 (2006) – Issue 2 – Article 44 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

Title Atrial natriuretic peptide suppresses left ventricular function and the renin-angiotensin-aldosterone system activity in normal and moderately atherosclerotic rabbits
Authors Konstantinos Kallaras¹, George Babas¹, Vassiliki Stergiou-Michailidou¹, Michael Karamouzis² and Thomas Zaraboukas³

Laboratories of 1. Experimental Physiology, 2. Biological Chemistry and 3. Pathology, Faculty of Medicine, Aristotle University, Thessaloniki, Greece

Citation Kallaras, K., Babas, G., Stergiou-Michailidou, V., Karamouzis, M., Zaraboukas, T.: Atrial natriuretic peptide suppresses left ventricular function and the renin-angiotensin-aldosterone system activity in normal and moderately atherosclerotic rabbits, Epitheorese Klin. Farmakol. Farmakokinet. 20(2): 181-184 (2006)
Publication Date Accepted for publication: 19-20 May 2006
Full Text Language English
Order – Buy  Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €) 

pharmakonpress[at]pharmakonpress[.]gr

Keywords ANP, atherosclerosis, left ventricle, angiotensin II, aldosterone.
Other Terms review article
Summary Atrial natriuretic peptide (ANP) has, in vivo, negative or no effect on left ventricular (LV) systole and relaxation. The aim of this study was to test the effect of ANP on LV function and on the renin-angiotensin-aldosterone system (RAAS) in normal and moderately atherosclerotic male anesthetized New Zealand White (NZW) rabbits. Each group’s individuals were divided into two subgroups of five animals each. Rabbits were rendered atherosclerotic by receiving for four weeks regular chow supplemented with 2% cholesterol and 6% corn oil. The LV and the left carotid artery were cannulated for left ventricular pressure (LVP) and blood pressure (BP) recordings, with concurrent ECG tracing. The left ventricular maximal pressure (LVPmax), the left ventricular end diastolic pressure (LVEDP), the maximal and the minimal change over time in LVP (LVmaxdp/dt and LVmindp/dt), the Δd (time interval between LVmax dpldt and LVmin dp/dt = systole duration) and the left ventricular ejection time (LVET) were estimated and the Double Product (heart rate X systolic blood pressure – HR x SBP) was calculated. Central venous pressure (CVP) was also recorded from the right jugular vein and blood samples were taken for lipids, ANP, plasma renin activity (PRA) and aldosterone (Ado) levels measurement. Recordings and blood samples for hormones measurement (by RIA) were taken at 0 min) and 20, 40, 60 min following an intravenous 20-min administration of either 0.2 µg/kg/min hANP in 5ml normal saline (NlS) or only 5ml NlS. The results were analyzed by t-test and repeated measures ANOVA. Mild to moderate atherosclerosis was found in rings of ascending aorta. ANP infusion resulted in decrease (p<0.05) of BP in 20min time only, but decrease (p<0.05) of LVPmax from 20min, decrease (p<0.05) of LVEDP and LVmaxdp/dt from 40 min, and less negative change (in- crease) (p<0.05) of LVmindp/dt from 40 min. DP was increased (p<0.05) from 20min only in atherosclerotic animals. PRA and aldo did not differ significantly at 0 min between atherosclerotic and normal; PRA in ANP receivers was smaller (p<0.01) whereas aldo tended to be smaller (p=0.06) than in N/S receivers. It is concluded that ANP administration, in doses to achieve levels approximately three fold the normal range, in normal and moderately atherosclerotic anesthetized NZW rabbits results in a negative effect on LV systolic function and relaxation and suppresses the RAAS activity independently of the atherosclerotic state.
References 1. Woods R.L., Oliver J.R., Korner P.I.: Direct and neurohumoral cardiovascular effects of atrial natriuretic peptide. J. Cardiovasc. Pharmacol. 13: 177-185 (1989)

2. Cody R.J., Atlas S.A., Laragh J.H., et al.: Atrial natriuretic factor in normal subjects and heart failure patients. J. Clin. Invest. 78: 1362-74 (1986)

3. Indolfi C., Piscione F., Volpe M., et al.: Cardiac effects of atrial natriuretic peptide in subjects with normal left ventricular function. Am. J. Cardiol. 63: 353-357 (1989)

4. Neyses L., Vetter H.: Impaired relaxation of the hypertrophied myocardium is potentiated by angiotensin II. J. Hyper- tens. 7(6):S104-5 (1989)

5. Tajima M., Bartunek J., Weinberg E.O., Ito N., Lorell B.H.: Atrial natriuretic peptide has different effects on contractility and intracellular pH in normal and hypertrophied myocytes from pressure-overloaded hearts. Circulation 98: 2760-2764 (1998)

6. Kon V., Jabs K.: Angiotensin in atherosclerosis. Curr. Opin. Nephrol. Hypertens. 13: 291-7 (2004)

7. Tallarida G., Iellamo F., Raimondi G., et al.: On the role of neural mechanisms in the cardiocirculatory inhibitory action of alpha-human atrial natriuretic peptide in the anesthesized rabbit. J. Hypertens. 9: 935-945 (1991)

8. Volpe M., Vecchione F., Cuocolo A., et al.: Hemodynamic responses to atrial natriuretic factor in nephrectomized rabbits: attenuation of the circulatory consequences of acute volume expansion. Circulation Res. 63: 322-329 (1988)

9. Volpe M., Sosa R.E., Muller F.B., et al.: Differing haemodynamic responses to atrial natriuretic factor in two models of hypertension. Am. J. Physiol. 250: H871-878 (1986)

10. Volpe M., Cuocolo A., Vecchione F., Mele A.F., Condorelli M., Trimarco B.: Vagal mediation of the effects of strial natriuretic factor on blood pressure and arterial baroreflexes in the rabbit. Circ. Res. 60: 747-755 (1987)

11. Rankin A.J., Swift F.V.: The inotropic effect of atrial natriuretic factor in the anesthesized rabbit. Pflugers Arch. 417: 353-359 (1990)

12. Ohte N., Cheng Che-Ping, Suzuki M., Little W.C.: Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. J. Pharm. Exp. Therap. 291: 589-595 (1999)

13. Shapiro J.T., Deleonardis V.M., Needleman P., Hintze T.H.: Integrated cardiac and peripheral vascular response to atriopeptin 24 in conscious dogs. Am. J. Physiol. 251: H1292- H1297 (1986)

14. Guyton A. Textbook of Medical Physiology. P. 107, Saunders Co., Philadelpia, 2000

15. Nushiro N., Abe K., Seino M., Itoh S., Yoshinaga K.: The effects of atrial natriuretic peptide on renal function and the renin-aldosterone system in anesthetized rabbits. Tohoku J. Exp. Med. 152: 301-310 (1987)

Relative Papers

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:

Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor

Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς – 
What is Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition-Instrunctions to Authors

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – 
Articles Published in Epitheorese Klinikes Farmakologias 
και Farmakokinetikes-International Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2006 – ANNUAL SUBSCRIPTION 2006
Γλώσσα Πλήρους Κειμένου – Full Text Language Αγγλικά – English
Παραγγελία – Αγορά – Order – Buy Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)

pharmakonpress[at]pharmakonpress[.]gr

Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)

pharmakonpress[at]pharmakonpress[.]gr

 

 

 

 

Bookmark the permalink.

Comments are closed.